CovidStanfordV1, Main, Exploration, bibRecord, 000250

TERAVOLT: Thoracic Cancers International COVID-19 Collaboration.

Identifieur interne : 000250 ( Main/Exploration ); précédent : 000249; suivant : 000251

TERAVOLT: Thoracic Cancers International COVID-19 Collaboration.

Auteurs : Jennifer G. Whisenant [États-Unis] ; Annalisa Trama [Italie] ; Valter Torri [Italie] ; Alessandro De Toma [Italie] ; Giuseppe Viscardi [Italie] ; Alessio Cortellini [Italie] ; Olivier Michielin [Suisse] ; Fabrice Barlesi [France] ; Anne-Marie C. Dingemans [Pays-Bas] ; Jan Van Meerbeeck [Belgique] ; Vera Pancaldi [Espagne] ; Ross A. Soo [Singapour] ; Natasha B. Leighl [Canada] ; Solange Peters [Suisse] ; Heather Wakelee [États-Unis] ; Marina Chiara Garassino [Italie] ; Leora Horn [États-Unis]

Source :

Cancer cell [ 1878-3686 ] ; 2020.

RBID : pubmed:32425702

Descripteurs français

KwdFr :
- Betacoronavirus (isolement et purification), Betacoronavirus (pathogénicité), Charge mondiale de morbidité (MeSH), Collaboration intersectorielle (MeSH), Coopération internationale (MeSH), Enregistrements (MeSH), Guides de bonnes pratiques cliniques comme sujet (MeSH), Humains (MeSH), Infections à coronavirus (complications), Infections à coronavirus (thérapie), Infections à coronavirus (virologie), Infections à coronavirus (épidémiologie), Oncologie médicale (normes), Oncologie médicale (organisation et administration), Pandémies (MeSH), Pneumopathie virale (complications), Pneumopathie virale (thérapie), Pneumopathie virale (virologie), Pneumopathie virale (épidémiologie), Tumeurs du thorax (complications), Tumeurs du thorax (mortalité), Tumeurs du thorax (thérapie).
MESH :
- isolement et purification : Betacoronavirus.
- mortalité : Tumeurs du thorax.
- normes : Oncologie médicale.
- organisation et administration : Oncologie médicale.
- pathogénicité : Betacoronavirus.
- thérapie : Infections à coronavirus, Pneumopathie virale, Tumeurs du thorax.
- virologie : Infections à coronavirus, Pneumopathie virale.
- épidémiologie : Infections à coronavirus, Pneumopathie virale.
- complications : Charge mondiale de morbidité, Collaboration intersectorielle, Coopération internationale, Enregistrements, Guides de bonnes pratiques cliniques comme sujet, Humains, Infections à coronavirus, Pandémies, Pneumopathie virale, Tumeurs du thorax.

English descriptors

KwdEn :
- Betacoronavirus (isolation & purification), Betacoronavirus (pathogenicity), COVID-19 (MeSH), Coronavirus Infections (complications), Coronavirus Infections (epidemiology), Coronavirus Infections (therapy), Coronavirus Infections (virology), Global Burden of Disease (MeSH), Humans (MeSH), International Cooperation (MeSH), Intersectoral Collaboration (MeSH), Medical Oncology (organization & administration), Medical Oncology (standards), Pandemics (MeSH), Pneumonia, Viral (complications), Pneumonia, Viral (epidemiology), Pneumonia, Viral (therapy), Pneumonia, Viral (virology), Practice Guidelines as Topic (MeSH), Registries (MeSH), SARS-CoV-2 (MeSH), Thoracic Neoplasms (complications), Thoracic Neoplasms (mortality), Thoracic Neoplasms (therapy).
MESH :
- complications : Coronavirus Infections, Pneumonia, Viral, Thoracic Neoplasms.
- epidemiology : Coronavirus Infections, Pneumonia, Viral.
- isolation & purification : Betacoronavirus.
- mortality : Thoracic Neoplasms.
- organization & administration : Medical Oncology.
- pathogenicity : Betacoronavirus.
- standards : Medical Oncology.
- therapy : Coronavirus Infections, Pneumonia, Viral, Thoracic Neoplasms.
- virology : Coronavirus Infections, Pneumonia, Viral.
- COVID-19, Global Burden of Disease, Humans, International Cooperation, Intersectoral Collaboration, Pandemics, Practice Guidelines as Topic, Registries, SARS-CoV-2.

Abstract

Prior publications on small subsets of cancer patients infected with SARS CoV-2 have shown an increased risk of mortality compared to the general population. Furthermore, patients with thoracic malignancies are thought to be at particularly high risk given their older age, smoking habits, and pre-existing cardio-pulmonary comorbidities. For this reason, physicians around the world have formed TERAVOLT, a global consortium dedicated to understanding the impact of COVID-19 on patients with thoracic malignancies.

DOI: 10.1016/j.ccell.2020.05.008
PubMed: 32425702
PubMed Central: PMC7229923

Affiliations:

Belgique, Canada, Espagne, France, Italie, Pays-Bas, Singapour, Suisse, États-Unis
Californie, Canton de Vaud, Catalogne, Lombardie, Ontario, Provence-Alpes-Côte d'Azur, Tennessee
Barcelone, Lausanne, Marseille, Milan, Stanford (Californie), Toronto
Université Stanford

Links toward previous steps (curation, corpus...)

to stream Main, to step Corpus: 000705
to stream Main, to step Curation: 000705

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">TERAVOLT: Thoracic Cancers International COVID-19 Collaboration.</title>
<author><name sortKey="Whisenant, Jennifer G" sort="Whisenant, Jennifer G" uniqKey="Whisenant J" first="Jennifer G" last="Whisenant">Jennifer G. Whisenant</name>
<affiliation wicri:level="2"><nlm:affiliation>Department of Medicine, Division of Hematology & Oncology, Vanderbilt University Medical Center, Nashville, TN, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Medicine, Division of Hematology & Oncology, Vanderbilt University Medical Center, Nashville, TN</wicri:regionArea>
<placeName><region type="state">Tennessee</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Trama, Annalisa" sort="Trama, Annalisa" uniqKey="Trama A" first="Annalisa" last="Trama">Annalisa Trama</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Research, Evaluative Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Research, Evaluative Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan</wicri:regionArea>
<placeName><settlement type="city">Milan</settlement>
<region nuts="2">Lombardie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Torri, Valter" sort="Torri, Valter" uniqKey="Torri V" first="Valter" last="Torri">Valter Torri</name>
<affiliation wicri:level="3"><nlm:affiliation>Laboratory of Clinical Research, Methodology Oncology Department "Mario Negri" Institute of Pharmacological Researches, IRCCS, Milan, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Laboratory of Clinical Research, Methodology Oncology Department "Mario Negri" Institute of Pharmacological Researches, IRCCS, Milan</wicri:regionArea>
<placeName><settlement type="city">Milan</settlement>
<region nuts="2">Lombardie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="De Toma, Alessandro" sort="De Toma, Alessandro" uniqKey="De Toma A" first="Alessandro" last="De Toma">Alessandro De Toma</name>
<affiliation wicri:level="3"><nlm:affiliation>Thoracic Oncology Unit, Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Thoracic Oncology Unit, Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan</wicri:regionArea>
<placeName><settlement type="city">Milan</settlement>
<region nuts="2">Lombardie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Viscardi, Giuseppe" sort="Viscardi, Giuseppe" uniqKey="Viscardi G" first="Giuseppe" last="Viscardi">Giuseppe Viscardi</name>
<affiliation wicri:level="3"><nlm:affiliation>Thoracic Oncology Unit, Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Thoracic Oncology Unit, Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan</wicri:regionArea>
<placeName><settlement type="city">Milan</settlement>
<region nuts="2">Lombardie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Cortellini, Alessio" sort="Cortellini, Alessio" uniqKey="Cortellini A" first="Alessio" last="Cortellini">Alessio Cortellini</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Biotechnology and Applied Clinical Science, University of L'Aquila, L'Aquila, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Biotechnology and Applied Clinical Science, University of L'Aquila, L'Aquila</wicri:regionArea>
<wicri:noRegion>L'Aquila</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Michielin, Olivier" sort="Michielin, Olivier" uniqKey="Michielin O" first="Olivier" last="Michielin">Olivier Michielin</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>Department of Oncology, Lausanne University Hospital, Lausanne</wicri:regionArea>
<placeName><settlement type="city">Lausanne</settlement>
<region nuts="3" type="region">Canton de Vaud</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Barlesi, Fabrice" sort="Barlesi, Fabrice" uniqKey="Barlesi F" first="Fabrice" last="Barlesi">Fabrice Barlesi</name>
<affiliation wicri:level="3"><nlm:affiliation>Gustave Roussy Cancer Center, Villejuif, France; Aix Marseille University, CNRS, INSERM, CRCM, Marseille, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Gustave Roussy Cancer Center, Villejuif, France; Aix Marseille University, CNRS, INSERM, CRCM, Marseille</wicri:regionArea>
<placeName><region type="region">Provence-Alpes-Côte d'Azur</region>
<region type="old region">Provence-Alpes-Côte d'Azur</region>
<settlement type="city">Marseille</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Dingemans, Anne Marie C" sort="Dingemans, Anne Marie C" uniqKey="Dingemans A" first="Anne-Marie C" last="Dingemans">Anne-Marie C. Dingemans</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Pulmonology, Erasmus University Medical Center, Rotterdam, University Maastricht, Maastricht, the Netherlands.</nlm:affiliation>
<country xml:lang="fr" wicri:curation="lc">Pays-Bas</country>
<wicri:regionArea>Department of Pulmonology, Erasmus University Medical Center, Rotterdam, University Maastricht, Maastricht</wicri:regionArea>
<wicri:noRegion>Maastricht</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Van Meerbeeck, Jan" sort="Van Meerbeeck, Jan" uniqKey="Van Meerbeeck J" first="Jan" last="Van Meerbeeck">Jan Van Meerbeeck</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Pulmonology and Thoracic Oncology, Antwerp University Hospital, Edegem, Belgium.</nlm:affiliation>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>Department of Pulmonology and Thoracic Oncology, Antwerp University Hospital, Edegem</wicri:regionArea>
<wicri:noRegion>Edegem</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Pancaldi, Vera" sort="Pancaldi, Vera" uniqKey="Pancaldi V" first="Vera" last="Pancaldi">Vera Pancaldi</name>
<affiliation wicri:level="3"><nlm:affiliation>Univeristy Paul Sabatier, Toulouse, Inserm, Centre de Recherche en Cancérologie de Toulouse, Toulouse, France, Barcelona Supercomputing Center, Barcelona.</nlm:affiliation>
<country>Espagne</country>
<placeName><settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
<wicri:orgArea>Univeristy Paul Sabatier, Toulouse, Inserm, Centre de Recherche en Cancérologie de Toulouse, Toulouse, France, Barcelona Supercomputing Center</wicri:orgArea>
</affiliation>
</author>
<author><name sortKey="Soo, Ross A" sort="Soo, Ross A" uniqKey="Soo R" first="Ross A" last="Soo">Ross A. Soo</name>
<affiliation wicri:level="1"><nlm:affiliation>National University Cancer Institute, Singapore.</nlm:affiliation>
<country xml:lang="fr">Singapour</country>
<wicri:regionArea>National University Cancer Institute</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Leighl, Natasha B" sort="Leighl, Natasha B" uniqKey="Leighl N" first="Natasha B" last="Leighl">Natasha B. Leighl</name>
<affiliation wicri:level="3"><nlm:affiliation>Princess Margaret Cancer Centre, Toronto, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Princess Margaret Cancer Centre, Toronto</wicri:regionArea>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Peters, Solange" sort="Peters, Solange" uniqKey="Peters S" first="Solange" last="Peters">Solange Peters</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>Department of Oncology, Lausanne University Hospital, Lausanne</wicri:regionArea>
<placeName><settlement type="city">Lausanne</settlement>
<region nuts="3" type="region">Canton de Vaud</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Wakelee, Heather" sort="Wakelee, Heather" uniqKey="Wakelee H" first="Heather" last="Wakelee">Heather Wakelee</name>
<affiliation wicri:level="4"><nlm:affiliation>Department of Medicine, Division of Oncology, Stanford Cancer Institute, Stanford University, Stanford, CA, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Medicine, Division of Oncology, Stanford Cancer Institute, Stanford University, Stanford, CA</wicri:regionArea>
<placeName><region type="state">Californie</region>
<settlement type="city">Stanford (Californie)</settlement>
</placeName>
<orgName type="university">Université Stanford</orgName>
</affiliation>
</author>
<author><name sortKey="Garassino, Marina Chiara" sort="Garassino, Marina Chiara" uniqKey="Garassino M" first="Marina Chiara" last="Garassino">Marina Chiara Garassino</name>
<affiliation wicri:level="3"><nlm:affiliation>Thoracic Oncology Unit, Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Electronic address: marina.garassino@istitutotumori.mi.it.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Thoracic Oncology Unit, Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan</wicri:regionArea>
<placeName><settlement type="city">Milan</settlement>
<region nuts="2">Lombardie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Horn, Leora" sort="Horn, Leora" uniqKey="Horn L" first="Leora" last="Horn">Leora Horn</name>
<affiliation wicri:level="2"><nlm:affiliation>Department of Medicine, Division of Hematology & Oncology, Vanderbilt University Medical Center, Nashville, TN, USA; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA. Electronic address: leora.horn@vumc.org.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Medicine, Division of Hematology & Oncology, Vanderbilt University Medical Center, Nashville, TN, USA; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN</wicri:regionArea>
<placeName><region type="state">Tennessee</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32425702</idno>
<idno type="pmid">32425702</idno>
<idno type="doi">10.1016/j.ccell.2020.05.008</idno>
<idno type="pmc">PMC7229923</idno>
<idno type="wicri:Area/Main/Corpus">000705</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000705</idno>
<idno type="wicri:Area/Main/Curation">000705</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000705</idno>
<idno type="wicri:Area/Main/Exploration">000705</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">TERAVOLT: Thoracic Cancers International COVID-19 Collaboration.</title>
<author><name sortKey="Whisenant, Jennifer G" sort="Whisenant, Jennifer G" uniqKey="Whisenant J" first="Jennifer G" last="Whisenant">Jennifer G. Whisenant</name>
<affiliation wicri:level="2"><nlm:affiliation>Department of Medicine, Division of Hematology & Oncology, Vanderbilt University Medical Center, Nashville, TN, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Medicine, Division of Hematology & Oncology, Vanderbilt University Medical Center, Nashville, TN</wicri:regionArea>
<placeName><region type="state">Tennessee</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Trama, Annalisa" sort="Trama, Annalisa" uniqKey="Trama A" first="Annalisa" last="Trama">Annalisa Trama</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Research, Evaluative Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Research, Evaluative Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan</wicri:regionArea>
<placeName><settlement type="city">Milan</settlement>
<region nuts="2">Lombardie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Torri, Valter" sort="Torri, Valter" uniqKey="Torri V" first="Valter" last="Torri">Valter Torri</name>
<affiliation wicri:level="3"><nlm:affiliation>Laboratory of Clinical Research, Methodology Oncology Department "Mario Negri" Institute of Pharmacological Researches, IRCCS, Milan, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Laboratory of Clinical Research, Methodology Oncology Department "Mario Negri" Institute of Pharmacological Researches, IRCCS, Milan</wicri:regionArea>
<placeName><settlement type="city">Milan</settlement>
<region nuts="2">Lombardie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="De Toma, Alessandro" sort="De Toma, Alessandro" uniqKey="De Toma A" first="Alessandro" last="De Toma">Alessandro De Toma</name>
<affiliation wicri:level="3"><nlm:affiliation>Thoracic Oncology Unit, Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Thoracic Oncology Unit, Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan</wicri:regionArea>
<placeName><settlement type="city">Milan</settlement>
<region nuts="2">Lombardie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Viscardi, Giuseppe" sort="Viscardi, Giuseppe" uniqKey="Viscardi G" first="Giuseppe" last="Viscardi">Giuseppe Viscardi</name>
<affiliation wicri:level="3"><nlm:affiliation>Thoracic Oncology Unit, Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Thoracic Oncology Unit, Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan</wicri:regionArea>
<placeName><settlement type="city">Milan</settlement>
<region nuts="2">Lombardie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Cortellini, Alessio" sort="Cortellini, Alessio" uniqKey="Cortellini A" first="Alessio" last="Cortellini">Alessio Cortellini</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Biotechnology and Applied Clinical Science, University of L'Aquila, L'Aquila, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Biotechnology and Applied Clinical Science, University of L'Aquila, L'Aquila</wicri:regionArea>
<wicri:noRegion>L'Aquila</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Michielin, Olivier" sort="Michielin, Olivier" uniqKey="Michielin O" first="Olivier" last="Michielin">Olivier Michielin</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>Department of Oncology, Lausanne University Hospital, Lausanne</wicri:regionArea>
<placeName><settlement type="city">Lausanne</settlement>
<region nuts="3" type="region">Canton de Vaud</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Barlesi, Fabrice" sort="Barlesi, Fabrice" uniqKey="Barlesi F" first="Fabrice" last="Barlesi">Fabrice Barlesi</name>
<affiliation wicri:level="3"><nlm:affiliation>Gustave Roussy Cancer Center, Villejuif, France; Aix Marseille University, CNRS, INSERM, CRCM, Marseille, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Gustave Roussy Cancer Center, Villejuif, France; Aix Marseille University, CNRS, INSERM, CRCM, Marseille</wicri:regionArea>
<placeName><region type="region">Provence-Alpes-Côte d'Azur</region>
<region type="old region">Provence-Alpes-Côte d'Azur</region>
<settlement type="city">Marseille</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Dingemans, Anne Marie C" sort="Dingemans, Anne Marie C" uniqKey="Dingemans A" first="Anne-Marie C" last="Dingemans">Anne-Marie C. Dingemans</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Pulmonology, Erasmus University Medical Center, Rotterdam, University Maastricht, Maastricht, the Netherlands.</nlm:affiliation>
<country xml:lang="fr" wicri:curation="lc">Pays-Bas</country>
<wicri:regionArea>Department of Pulmonology, Erasmus University Medical Center, Rotterdam, University Maastricht, Maastricht</wicri:regionArea>
<wicri:noRegion>Maastricht</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Van Meerbeeck, Jan" sort="Van Meerbeeck, Jan" uniqKey="Van Meerbeeck J" first="Jan" last="Van Meerbeeck">Jan Van Meerbeeck</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Pulmonology and Thoracic Oncology, Antwerp University Hospital, Edegem, Belgium.</nlm:affiliation>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>Department of Pulmonology and Thoracic Oncology, Antwerp University Hospital, Edegem</wicri:regionArea>
<wicri:noRegion>Edegem</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Pancaldi, Vera" sort="Pancaldi, Vera" uniqKey="Pancaldi V" first="Vera" last="Pancaldi">Vera Pancaldi</name>
<affiliation wicri:level="3"><nlm:affiliation>Univeristy Paul Sabatier, Toulouse, Inserm, Centre de Recherche en Cancérologie de Toulouse, Toulouse, France, Barcelona Supercomputing Center, Barcelona.</nlm:affiliation>
<country>Espagne</country>
<placeName><settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
<wicri:orgArea>Univeristy Paul Sabatier, Toulouse, Inserm, Centre de Recherche en Cancérologie de Toulouse, Toulouse, France, Barcelona Supercomputing Center</wicri:orgArea>
</affiliation>
</author>
<author><name sortKey="Soo, Ross A" sort="Soo, Ross A" uniqKey="Soo R" first="Ross A" last="Soo">Ross A. Soo</name>
<affiliation wicri:level="1"><nlm:affiliation>National University Cancer Institute, Singapore.</nlm:affiliation>
<country xml:lang="fr">Singapour</country>
<wicri:regionArea>National University Cancer Institute</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Leighl, Natasha B" sort="Leighl, Natasha B" uniqKey="Leighl N" first="Natasha B" last="Leighl">Natasha B. Leighl</name>
<affiliation wicri:level="3"><nlm:affiliation>Princess Margaret Cancer Centre, Toronto, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Princess Margaret Cancer Centre, Toronto</wicri:regionArea>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Peters, Solange" sort="Peters, Solange" uniqKey="Peters S" first="Solange" last="Peters">Solange Peters</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>Department of Oncology, Lausanne University Hospital, Lausanne</wicri:regionArea>
<placeName><settlement type="city">Lausanne</settlement>
<region nuts="3" type="region">Canton de Vaud</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Wakelee, Heather" sort="Wakelee, Heather" uniqKey="Wakelee H" first="Heather" last="Wakelee">Heather Wakelee</name>
<affiliation wicri:level="4"><nlm:affiliation>Department of Medicine, Division of Oncology, Stanford Cancer Institute, Stanford University, Stanford, CA, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Medicine, Division of Oncology, Stanford Cancer Institute, Stanford University, Stanford, CA</wicri:regionArea>
<placeName><region type="state">Californie</region>
<settlement type="city">Stanford (Californie)</settlement>
</placeName>
<orgName type="university">Université Stanford</orgName>
</affiliation>
</author>
<author><name sortKey="Garassino, Marina Chiara" sort="Garassino, Marina Chiara" uniqKey="Garassino M" first="Marina Chiara" last="Garassino">Marina Chiara Garassino</name>
<affiliation wicri:level="3"><nlm:affiliation>Thoracic Oncology Unit, Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Electronic address: marina.garassino@istitutotumori.mi.it.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Thoracic Oncology Unit, Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan</wicri:regionArea>
<placeName><settlement type="city">Milan</settlement>
<region nuts="2">Lombardie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Horn, Leora" sort="Horn, Leora" uniqKey="Horn L" first="Leora" last="Horn">Leora Horn</name>
<affiliation wicri:level="2"><nlm:affiliation>Department of Medicine, Division of Hematology & Oncology, Vanderbilt University Medical Center, Nashville, TN, USA; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA. Electronic address: leora.horn@vumc.org.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Medicine, Division of Hematology & Oncology, Vanderbilt University Medical Center, Nashville, TN, USA; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN</wicri:regionArea>
<placeName><region type="state">Tennessee</region>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j">Cancer cell</title>
<idno type="eISSN">1878-3686</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Betacoronavirus (isolation & purification)</term>
<term>Betacoronavirus (pathogenicity)</term>
<term>COVID-19 (MeSH)</term>
<term>Coronavirus Infections (complications)</term>
<term>Coronavirus Infections (epidemiology)</term>
<term>Coronavirus Infections (therapy)</term>
<term>Coronavirus Infections (virology)</term>
<term>Global Burden of Disease (MeSH)</term>
<term>Humans (MeSH)</term>
<term>International Cooperation (MeSH)</term>
<term>Intersectoral Collaboration (MeSH)</term>
<term>Medical Oncology (organization & administration)</term>
<term>Medical Oncology (standards)</term>
<term>Pandemics (MeSH)</term>
<term>Pneumonia, Viral (complications)</term>
<term>Pneumonia, Viral (epidemiology)</term>
<term>Pneumonia, Viral (therapy)</term>
<term>Pneumonia, Viral (virology)</term>
<term>Practice Guidelines as Topic (MeSH)</term>
<term>Registries (MeSH)</term>
<term>SARS-CoV-2 (MeSH)</term>
<term>Thoracic Neoplasms (complications)</term>
<term>Thoracic Neoplasms (mortality)</term>
<term>Thoracic Neoplasms (therapy)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Betacoronavirus (isolement et purification)</term>
<term>Betacoronavirus (pathogénicité)</term>
<term>Charge mondiale de morbidité (MeSH)</term>
<term>Collaboration intersectorielle (MeSH)</term>
<term>Coopération internationale (MeSH)</term>
<term>Enregistrements (MeSH)</term>
<term>Guides de bonnes pratiques cliniques comme sujet (MeSH)</term>
<term>Humains (MeSH)</term>
<term>Infections à coronavirus (complications)</term>
<term>Infections à coronavirus (thérapie)</term>
<term>Infections à coronavirus (virologie)</term>
<term>Infections à coronavirus (épidémiologie)</term>
<term>Oncologie médicale (normes)</term>
<term>Oncologie médicale (organisation et administration)</term>
<term>Pandémies (MeSH)</term>
<term>Pneumopathie virale (complications)</term>
<term>Pneumopathie virale (thérapie)</term>
<term>Pneumopathie virale (virologie)</term>
<term>Pneumopathie virale (épidémiologie)</term>
<term>Tumeurs du thorax (complications)</term>
<term>Tumeurs du thorax (mortalité)</term>
<term>Tumeurs du thorax (thérapie)</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
<term>Thoracic Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en"><term>Betacoronavirus</term>
</keywords>
<keywords scheme="MESH" qualifier="isolement et purification" xml:lang="fr"><term>Betacoronavirus</term>
</keywords>
<keywords scheme="MESH" qualifier="mortality" xml:lang="en"><term>Thoracic Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="mortalité" xml:lang="fr"><term>Tumeurs du thorax</term>
</keywords>
<keywords scheme="MESH" qualifier="normes" xml:lang="fr"><term>Oncologie médicale</term>
</keywords>
<keywords scheme="MESH" qualifier="organisation et administration" xml:lang="fr"><term>Oncologie médicale</term>
</keywords>
<keywords scheme="MESH" qualifier="organization & administration" xml:lang="en"><term>Medical Oncology</term>
</keywords>
<keywords scheme="MESH" qualifier="pathogenicity" xml:lang="en"><term>Betacoronavirus</term>
</keywords>
<keywords scheme="MESH" qualifier="pathogénicité" xml:lang="fr"><term>Betacoronavirus</term>
</keywords>
<keywords scheme="MESH" qualifier="standards" xml:lang="en"><term>Medical Oncology</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
<term>Thoracic Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="thérapie" xml:lang="fr"><term>Infections à coronavirus</term>
<term>Pneumopathie virale</term>
<term>Tumeurs du thorax</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Infections à coronavirus</term>
<term>Pneumopathie virale</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Infections à coronavirus</term>
<term>Pneumopathie virale</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>COVID-19</term>
<term>Global Burden of Disease</term>
<term>Humans</term>
<term>International Cooperation</term>
<term>Intersectoral Collaboration</term>
<term>Pandemics</term>
<term>Practice Guidelines as Topic</term>
<term>Registries</term>
<term>SARS-CoV-2</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="fr"><term>Charge mondiale de morbidité</term>
<term>Collaboration intersectorielle</term>
<term>Coopération internationale</term>
<term>Enregistrements</term>
<term>Guides de bonnes pratiques cliniques comme sujet</term>
<term>Humains</term>
<term>Infections à coronavirus</term>
<term>Pandémies</term>
<term>Pneumopathie virale</term>
<term>Tumeurs du thorax</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Prior publications on small subsets of cancer patients infected with SARS CoV-2 have shown an increased risk of mortality compared to the general population. Furthermore, patients with thoracic malignancies are thought to be at particularly high risk given their older age, smoking habits, and pre-existing cardio-pulmonary comorbidities. For this reason, physicians around the world have formed TERAVOLT, a global consortium dedicated to understanding the impact of COVID-19 on patients with thoracic malignancies.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32425702</PMID>
<DateCompleted><Year>2020</Year>
<Month>06</Month>
<Day>22</Day>
</DateCompleted>
<DateRevised><Year>2021</Year>
<Month>01</Month>
<Day>10</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1878-3686</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>37</Volume>
<Issue>6</Issue>
<PubDate><Year>2020</Year>
<Month>06</Month>
<Day>08</Day>
</PubDate>
</JournalIssue>
<Title>Cancer cell</Title>
<ISOAbbreviation>Cancer Cell</ISOAbbreviation>
</Journal>
<ArticleTitle>TERAVOLT: Thoracic Cancers International COVID-19 Collaboration.</ArticleTitle>
<Pagination><MedlinePgn>742-745</MedlinePgn>
</Pagination>
<ELocationID EIdType="pii" ValidYN="Y">S1535-6108(20)30258-0</ELocationID>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ccell.2020.05.008</ELocationID>
<Abstract><AbstractText>Prior publications on small subsets of cancer patients infected with SARS CoV-2 have shown an increased risk of mortality compared to the general population. Furthermore, patients with thoracic malignancies are thought to be at particularly high risk given their older age, smoking habits, and pre-existing cardio-pulmonary comorbidities. For this reason, physicians around the world have formed TERAVOLT, a global consortium dedicated to understanding the impact of COVID-19 on patients with thoracic malignancies.</AbstractText>
<CopyrightInformation>Copyright © 2020. Published by Elsevier Inc.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Whisenant</LastName>
<ForeName>Jennifer G</ForeName>
<Initials>JG</Initials>
<AffiliationInfo><Affiliation>Department of Medicine, Division of Hematology & Oncology, Vanderbilt University Medical Center, Nashville, TN, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Trama</LastName>
<ForeName>Annalisa</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Department of Research, Evaluative Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Torri</LastName>
<ForeName>Valter</ForeName>
<Initials>V</Initials>
<AffiliationInfo><Affiliation>Laboratory of Clinical Research, Methodology Oncology Department "Mario Negri" Institute of Pharmacological Researches, IRCCS, Milan, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>De Toma</LastName>
<ForeName>Alessandro</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Thoracic Oncology Unit, Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Viscardi</LastName>
<ForeName>Giuseppe</ForeName>
<Initials>G</Initials>
<AffiliationInfo><Affiliation>Thoracic Oncology Unit, Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Cortellini</LastName>
<ForeName>Alessio</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Department of Biotechnology and Applied Clinical Science, University of L'Aquila, L'Aquila, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Michielin</LastName>
<ForeName>Olivier</ForeName>
<Initials>O</Initials>
<AffiliationInfo><Affiliation>Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Barlesi</LastName>
<ForeName>Fabrice</ForeName>
<Initials>F</Initials>
<AffiliationInfo><Affiliation>Gustave Roussy Cancer Center, Villejuif, France; Aix Marseille University, CNRS, INSERM, CRCM, Marseille, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Dingemans</LastName>
<ForeName>Anne-Marie C</ForeName>
<Initials>AC</Initials>
<AffiliationInfo><Affiliation>Department of Pulmonology, Erasmus University Medical Center, Rotterdam, University Maastricht, Maastricht, the Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Van Meerbeeck</LastName>
<ForeName>Jan</ForeName>
<Initials>J</Initials>
<AffiliationInfo><Affiliation>Department of Pulmonology and Thoracic Oncology, Antwerp University Hospital, Edegem, Belgium.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Pancaldi</LastName>
<ForeName>Vera</ForeName>
<Initials>V</Initials>
<AffiliationInfo><Affiliation>Univeristy Paul Sabatier, Toulouse, Inserm, Centre de Recherche en Cancérologie de Toulouse, Toulouse, France, Barcelona Supercomputing Center, Barcelona.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Soo</LastName>
<ForeName>Ross A</ForeName>
<Initials>RA</Initials>
<AffiliationInfo><Affiliation>National University Cancer Institute, Singapore.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Leighl</LastName>
<ForeName>Natasha B</ForeName>
<Initials>NB</Initials>
<AffiliationInfo><Affiliation>Princess Margaret Cancer Centre, Toronto, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Peters</LastName>
<ForeName>Solange</ForeName>
<Initials>S</Initials>
<AffiliationInfo><Affiliation>Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Wakelee</LastName>
<ForeName>Heather</ForeName>
<Initials>H</Initials>
<AffiliationInfo><Affiliation>Department of Medicine, Division of Oncology, Stanford Cancer Institute, Stanford University, Stanford, CA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Garassino</LastName>
<ForeName>Marina Chiara</ForeName>
<Initials>MC</Initials>
<AffiliationInfo><Affiliation>Thoracic Oncology Unit, Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Electronic address: marina.garassino@istitutotumori.mi.it.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Horn</LastName>
<ForeName>Leora</ForeName>
<Initials>L</Initials>
<AffiliationInfo><Affiliation>Department of Medicine, Division of Hematology & Oncology, Vanderbilt University Medical Center, Nashville, TN, USA; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA. Electronic address: leora.horn@vumc.org.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y"><Grant><GrantID>UL1 TR000445</GrantID>
<Acronym>TR</Acronym>
<Agency>NCATS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2020</Year>
<Month>05</Month>
<Day>16</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Cancer Cell</MedlineTA>
<NlmUniqueID>101130617</NlmUniqueID>
<ISSNLinking>1535-6108</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName>
<QualifierName UI="Q000302" MajorTopicYN="Y">isolation & purification</QualifierName>
<QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000071219" MajorTopicYN="N">Global Burden of Disease</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007391" MajorTopicYN="N">International Cooperation</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000070516" MajorTopicYN="N">Intersectoral Collaboration</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008495" MajorTopicYN="N">Medical Oncology</DescriptorName>
<QualifierName UI="Q000458" MajorTopicYN="Y">organization & administration</QualifierName>
<QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D017410" MajorTopicYN="N">Practice Guidelines as Topic</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012042" MajorTopicYN="Y">Registries</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013899" MajorTopicYN="N">Thoracic Neoplasms</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
<QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
</MeshHeading>
</MeshHeadingList>
<CoiStatement>Declaration of Interests A.C. reports grants and personal fees from MSD, grants from Roche, grants from BMS, grants and personal fees from Astra-Zeneca, grants from Novartis, and personal fees from Astellas outside the submitted work. S.P. has received education grants, provided consultation, attended advisory board meetings, and provided lectures for Abbvie, Amgen, AstraZeneca, Bayer, Biocartis, Bioinvent, Blueprint Medicines, Boehringer-Ingelheim, Bristol-Myers Squibb, Clovis, Daiichi Sankyo, Debiopharm, Eli Lilly, F. Hoffmann-La Roche, Foundation Medicine, Illumina, Janssen, Merck Sharp and Dohme, Merck Serono, Merrimack, Novartis, Pharma Mar, Pfizer, Regeneron, Sanofi, Seattle Genetics, Takeda, and Vaccibody, from whom she has received honoraria (all fees to institution). H.W. reports a leadership role in IASLC. M.C.G. reports personal fees from Bayer, personal fees and other from Eli Lilly, personal fees from Boehringer Ingelheim, personal fees from Otsuka Pharma, Seattle Genetics and Daiichi Sankyo, personal fees and other from Astra Zeneca, personal fees and other from Novartis, personal fees and other from BMS, personal fees and other from Roche, personal fees and other from Pfizer, personal fees and other from Celgene, personal fees from Incyte, personal fees from Inivata, personal fees from Takeda, other from Tiziana Sciences, other from Clovis, other from GSK, personal fees from Sanofi-Aventis, and other from Spectrum Pharmaceutcials, Blueprint Medicine outside the submitted work. L.H. reports consulting for Astra Zeneca, Incyte, Amgen, EMD Serono, Bayer, Merck, Pfizer, Genentech-Roche, and Xcovery and research funding from Bristol Myers Squibb, Xcovery, and Boehringer Ingelheim. No other authors have disclosures to report.</CoiStatement>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>5</Month>
<Day>20</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>6</Month>
<Day>23</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>5</Month>
<Day>20</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">32425702</ArticleId>
<ArticleId IdType="doi">10.1016/j.ccell.2020.05.008</ArticleId>
<ArticleId IdType="pii">S1535-6108(20)30258-0</ArticleId>
<ArticleId IdType="pmc">PMC7229923</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Cancer Discov. 2020 Jun;10(6):783-791</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32345594</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA. 2020 Mar 17;323(11):1061-1069</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32031570</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2020 Apr 30;382(18):1708-1720</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32109013</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Thromb Haemost. 2020 Jul;18(7):1747-1751</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32302448</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA Oncol. 2020 Jul 1;6(7):1108-1110</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32211820</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cancer Discov. 2020 Jul;10(7):935-941</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32357994</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JCO Glob Oncol. 2020 Apr;6:557-559</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32250659</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2020 Feb 15;395(10223):473-475</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32043983</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Biomed Inform. 2019 Jul;95:103208</Citation>
<ArticleIdList><ArticleId IdType="pubmed">31078660</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2020 Feb 15;395(10223):507-513</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32007143</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Belgique</li>
<li>Canada</li>
<li>Espagne</li>
<li>France</li>
<li>Italie</li>
<li>Pays-Bas</li>
<li>Singapour</li>
<li>Suisse</li>
<li>États-Unis</li>
</country>
<region><li>Californie</li>
<li>Canton de Vaud</li>
<li>Catalogne</li>
<li>Lombardie</li>
<li>Ontario</li>
<li>Provence-Alpes-Côte d'Azur</li>
<li>Tennessee</li>
</region>
<settlement><li>Barcelone</li>
<li>Lausanne</li>
<li>Marseille</li>
<li>Milan</li>
<li>Stanford (Californie)</li>
<li>Toronto</li>
</settlement>
<orgName><li>Université Stanford</li>
</orgName>
</list>
<tree><country name="États-Unis"><region name="Tennessee"><name sortKey="Whisenant, Jennifer G" sort="Whisenant, Jennifer G" uniqKey="Whisenant J" first="Jennifer G" last="Whisenant">Jennifer G. Whisenant</name>
</region>
<name sortKey="Horn, Leora" sort="Horn, Leora" uniqKey="Horn L" first="Leora" last="Horn">Leora Horn</name>
<name sortKey="Wakelee, Heather" sort="Wakelee, Heather" uniqKey="Wakelee H" first="Heather" last="Wakelee">Heather Wakelee</name>
</country>
<country name="Italie"><region name="Lombardie"><name sortKey="Trama, Annalisa" sort="Trama, Annalisa" uniqKey="Trama A" first="Annalisa" last="Trama">Annalisa Trama</name>
</region>
<name sortKey="Cortellini, Alessio" sort="Cortellini, Alessio" uniqKey="Cortellini A" first="Alessio" last="Cortellini">Alessio Cortellini</name>
<name sortKey="De Toma, Alessandro" sort="De Toma, Alessandro" uniqKey="De Toma A" first="Alessandro" last="De Toma">Alessandro De Toma</name>
<name sortKey="Garassino, Marina Chiara" sort="Garassino, Marina Chiara" uniqKey="Garassino M" first="Marina Chiara" last="Garassino">Marina Chiara Garassino</name>
<name sortKey="Torri, Valter" sort="Torri, Valter" uniqKey="Torri V" first="Valter" last="Torri">Valter Torri</name>
<name sortKey="Viscardi, Giuseppe" sort="Viscardi, Giuseppe" uniqKey="Viscardi G" first="Giuseppe" last="Viscardi">Giuseppe Viscardi</name>
</country>
<country name="Suisse"><region name="Canton de Vaud"><name sortKey="Michielin, Olivier" sort="Michielin, Olivier" uniqKey="Michielin O" first="Olivier" last="Michielin">Olivier Michielin</name>
</region>
<name sortKey="Peters, Solange" sort="Peters, Solange" uniqKey="Peters S" first="Solange" last="Peters">Solange Peters</name>
</country>
<country name="France"><region name="Provence-Alpes-Côte d'Azur"><name sortKey="Barlesi, Fabrice" sort="Barlesi, Fabrice" uniqKey="Barlesi F" first="Fabrice" last="Barlesi">Fabrice Barlesi</name>
</region>
</country>
<country name="Pays-Bas"><noRegion><name sortKey="Dingemans, Anne Marie C" sort="Dingemans, Anne Marie C" uniqKey="Dingemans A" first="Anne-Marie C" last="Dingemans">Anne-Marie C. Dingemans</name>
</noRegion>
</country>
<country name="Belgique"><noRegion><name sortKey="Van Meerbeeck, Jan" sort="Van Meerbeeck, Jan" uniqKey="Van Meerbeeck J" first="Jan" last="Van Meerbeeck">Jan Van Meerbeeck</name>
</noRegion>
</country>
<country name="Espagne"><region name="Catalogne"><name sortKey="Pancaldi, Vera" sort="Pancaldi, Vera" uniqKey="Pancaldi V" first="Vera" last="Pancaldi">Vera Pancaldi</name>
</region>
</country>
<country name="Singapour"><noRegion><name sortKey="Soo, Ross A" sort="Soo, Ross A" uniqKey="Soo R" first="Ross A" last="Soo">Ross A. Soo</name>
</noRegion>
</country>
<country name="Canada"><region name="Ontario"><name sortKey="Leighl, Natasha B" sort="Leighl, Natasha B" uniqKey="Leighl N" first="Natasha B" last="Leighl">Natasha B. Leighl</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidStanfordV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000250 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000250 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidStanfordV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:32425702
   |texte=   TERAVOLT: Thoracic Cancers International COVID-19 Collaboration.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:32425702" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidStanfordV1

This area was generated with Dilib version V0.6.38.
Data generation: Tue Feb 2 21:24:25 2021. Site generation: Tue Feb 2 21:26:08 2021

	Serveur d'exploration sur le Covid à Stanford
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur le Covid à Stanford

TERAVOLT: Thoracic Cancers International COVID-19 Collaboration.

TERAVOLT: Thoracic Cancers International COVID-19 Collaboration.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki